Prevalence of Porphyromonas Gingivalis Fimbrial Subunit Genotype in Smokers and Nonsmokers After Periodontal Therapy
Sponsor: Universidade Federal Fluminense
Listed as NCT02879903, this EARLY_PHASE1 trial focuses on Chronic Periodontitis and remains ongoing. Sponsored by Universidade Federal Fluminense, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown EARLY_PHASE1
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status EARLY_PHASE1
-
Sep 2018 — Jan 2021 [monthly]
Unknown Status EARLY_PHASE1
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting EARLY_PHASE1
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting Phase 0
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Universidade Federal Fluminense
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.